Bayer (FRA:BAYN) Share Price Crosses Below Fifty Day Moving Average of $55.84

Shares of Bayer AG (FRA:BAYN) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $55.84 and traded as low as $58.99. Bayer shares last traded at $59.14, with a volume of 2,146,429 shares trading hands.

A number of research firms have recently commented on BAYN. Barclays upped their target price on Intuit from $225.00 to $237.00 and gave the company an “equal weight” rating in a research note on Friday, May 24th. Credit Suisse Group set a $43.00 target price on shares of SEA and gave the company a “buy” rating in a research note on Thursday, July 4th. Societe Generale set a €105.00 ($122.09) target price on shares of Merck KGaA and gave the company a “neutral” rating in a research note on Wednesday, March 27th. Baader Bank set a €123.00 ($143.02) target price on shares of Bayer and gave the company a “buy” rating in a research note on Thursday, June 27th. Finally, DZ Bank upgraded shares of Telefonica from a “hold” rating to a “buy” rating in a research note on Tuesday, May 14th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have given a buy rating to the stock. Bayer presently has an average rating of “Hold” and a consensus price target of €80.63 ($93.76).

The stock’s fifty day simple moving average is €55.91.

About Bayer (FRA:BAYN)

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Read More: What is a Candlestick Chart?

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.